reduced glutathione sublingual complex L-Glutathione Sublingual Glutathione Capsules | Liquid

Produces a depletion of releasable neuronal monoamine neurotransmitters Reserpine's effects produce a reduction in blood pressure due to a decreased cardiac output & decreased peripheral vascular resistance Figure 1

It helps in minimizing the chain reactions created by free radicals and the oxidative stress that breaks down your cellular walls

AGROSAF LAL DANT MANJAN AGROSAF LIP CARE BALM AGROSAF MOSQUITO REPELLENT SPRAY AGROSAF ROSE & JASMINE BODY WASH -Rose & Jasmine Bady Wash (rehydrating & Purifying) AGROSAF ROSE MIST FACE TONER - Rose Mist Face Toner(for All Skin Types) AGROSAF VITAMIN C SERUM - Vitamin C Serum Reduce Dark Spot & Pigmentation Boost Glow & Even Out Skin Tone AGROSAF WOMEN HYGIENE WASH - Unique Ph 3.5* Balance Formula Of Lactic Acid Enriched With Sea Buckthron & Tea Tree Oil ALODEV LS JUNIOR DROP ALODEV RESPULE - SALBUTAMOL NEBULISER SOLUTION 2.5ML AROZINE DROP - Hydroxyzine (6mg) AVIRAMOX JUNIOR DROP -AMOXYCILLIN 80MG & POTASSIUM CLAVULANATE 11.4MG DROP BICODIS TABLET - SODIUM BICARBONATE 500MG TABLET BILOSAF M SUSPENSION BECLOSAFE PAIN RELIEF BALM BECLOSAFE PAIN RELIEF OIL BECLOSAFE PAIN RELIEF OINTMENT -PAIN RELIEF OINTMENT BECLOSAFE PAIN RELIEF ROLL ON - Diclofenac 1.16 %,methyl Salisylate 10 %,linseed Oil 3 %,menthol 5 % Benzyl Alcohol 1 % BECLOSAFE PAIN RELIEF SPRAY - Diclofenac Diethylamine Ip 1.16%w/w Eq.to.dicofenac Sodium Ip 1.00%w/w+virgin Linseed Oil Bp 3% W/w+methyl Salicylate Ip 10% W/w+menthol Ip 5% W/w BUDILITE 0.5 MG RESPULE - BUDESONITE(0.5MG) BUDILITE 1MG RESPULE - BUDESONITE(1MG) BUDILITE L RESPULE - Budesonide (0.5mg)+Levosalbutamol (1.25mg) BURNOSAFE CREAM CALSAFE B 15GM CREAM CANOZOLE DUSTING POWDER 100GM CANOZOLE GOLD CREAM - Clotrimazole (1% w/v) with Almond Oil CANOZOLE GOLD CREAM CANOZOLE GOLD POWDER BETASAFE 10% SOLUTION 100 ML BETASAFE 10% SOLUTION 200ML CANOZOLE MOUTH PAINT -Clotrimazole (1% w/w) CANOZOLE POWDER 250 GM CANOZOLE POWDER 50GM - Clotrimazole I.P

meaning no side effects such as what we see with pharmaceuticals

The Funds must take reasonable steps to verify the accredited investor status of each potential investor in order to make use of the exemption under Rule 506(c) of Regulation D and potential investors must be prepared to provide documentation to the Funds or third-party agents or representatives to support their qualification